Actionable news
All posts from Actionable news
Actionable news in NWBO: Northwest Biotherapeutics, Inc.,

Entry into a Material Definitive

Effective October 21, 2015, Northwest Biotherapeutics, Inc., a Delaware corporation (the Company), entered into a stock purchase agreement (the Agreement) with Woodford Investment Management LLP as agent for the CF Woodford Equity Income Fund and other clients (collectively, Woodford). Pursuant to the Agreement, the Company has agreed to sell, and Woodford has agreed to purchase, 5,454,545 shares of the Companys common stock, par value $0.001 per share (the Shares), at a purchase price of $5.50 per share for an aggregate purchase price of $30,000,000 (the Woodford Financing). The Company has agreed to register the Shares in a registration statement with the U. S. Securities and Exchange Commission.

The foregoing description of the Agreement does not purpo rt to be complete and is qualified in its entirety by reference to the Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by...